Current Perspectives on Role of MSC in Renal Pathophysiology

In the course of the development and worsening of kidney disease, the treatments available are expensive and may cause adverse effects such as immune rejection, inadequate renal resources, or post-operative complications. Therefore, there is an urgent to develop more effective treatments. The advent...

Full description

Bibliographic Details
Main Authors: Min Fan, Jing Zhang, Hong Xin, Xiaozhou He, Xuemei Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-09-01
Series:Frontiers in Physiology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fphys.2018.01323/full
id doaj-a64c03a594654077b50e6fab5045d869
record_format Article
spelling doaj-a64c03a594654077b50e6fab5045d8692020-11-24T21:14:36ZengFrontiers Media S.A.Frontiers in Physiology1664-042X2018-09-01910.3389/fphys.2018.01323370852Current Perspectives on Role of MSC in Renal PathophysiologyMin Fan0Jing Zhang1Hong Xin2Xiaozhou He3Xuemei Zhang4The Third Affiliated Hospital of Soochow University, Changzhou, ChinaDepartment of Pharmacology, School of Pharmacy, Fudan University, Shanghai, ChinaDepartment of Pharmacology, School of Pharmacy, Fudan University, Shanghai, ChinaThe Third Affiliated Hospital of Soochow University, Changzhou, ChinaDepartment of Pharmacology, School of Pharmacy, Fudan University, Shanghai, ChinaIn the course of the development and worsening of kidney disease, the treatments available are expensive and may cause adverse effects such as immune rejection, inadequate renal resources, or post-operative complications. Therefore, there is an urgent to develop more effective treatments. The advent of mesenchymal stem cells (MSCs) represents a new direction in this context. The current use of MSCs for the treatment of kidney disease has mostly involved experimental studies on animals and only a few clinical trials have been conducted. This review focused on the mechanisms of MSC involvement from different sources in the improvement of renal pathophysiology in recent years. These mechanisms include homing to damaged kidney tissue, and differentiating into or fusing with the innate cells of the kidney. The paracrine or endocrine action through secreting protective cytokines and/or releasing microvesicle from MSCs also plays a critical role in amelioration of kidney disease. With modern engineering technology like microRNA delivery and a combinational therapy approach such as reduction of renal fibrosis in obstructive nephropathy with MSCs and serelaxin, MSC may make great contribution to the improvement of renal pathophysiology. However, the therapeutic effects of MSC are still controversial and several problems remain unsolved. While it is too early to state that MSCs are useful for the treatment of renal diseases in clinic, it is thought that solutions to the existing problems will enable effective modulation of the biological characteristics of MSCs, thereby providing new and effective approaches for the treatment of renal diseases.https://www.frontiersin.org/article/10.3389/fphys.2018.01323/fullmesenchymal stem cellrenal fibrosisregenerative therapyhomingautocrineparacrine
collection DOAJ
language English
format Article
sources DOAJ
author Min Fan
Jing Zhang
Hong Xin
Xiaozhou He
Xuemei Zhang
spellingShingle Min Fan
Jing Zhang
Hong Xin
Xiaozhou He
Xuemei Zhang
Current Perspectives on Role of MSC in Renal Pathophysiology
Frontiers in Physiology
mesenchymal stem cell
renal fibrosis
regenerative therapy
homing
autocrine
paracrine
author_facet Min Fan
Jing Zhang
Hong Xin
Xiaozhou He
Xuemei Zhang
author_sort Min Fan
title Current Perspectives on Role of MSC in Renal Pathophysiology
title_short Current Perspectives on Role of MSC in Renal Pathophysiology
title_full Current Perspectives on Role of MSC in Renal Pathophysiology
title_fullStr Current Perspectives on Role of MSC in Renal Pathophysiology
title_full_unstemmed Current Perspectives on Role of MSC in Renal Pathophysiology
title_sort current perspectives on role of msc in renal pathophysiology
publisher Frontiers Media S.A.
series Frontiers in Physiology
issn 1664-042X
publishDate 2018-09-01
description In the course of the development and worsening of kidney disease, the treatments available are expensive and may cause adverse effects such as immune rejection, inadequate renal resources, or post-operative complications. Therefore, there is an urgent to develop more effective treatments. The advent of mesenchymal stem cells (MSCs) represents a new direction in this context. The current use of MSCs for the treatment of kidney disease has mostly involved experimental studies on animals and only a few clinical trials have been conducted. This review focused on the mechanisms of MSC involvement from different sources in the improvement of renal pathophysiology in recent years. These mechanisms include homing to damaged kidney tissue, and differentiating into or fusing with the innate cells of the kidney. The paracrine or endocrine action through secreting protective cytokines and/or releasing microvesicle from MSCs also plays a critical role in amelioration of kidney disease. With modern engineering technology like microRNA delivery and a combinational therapy approach such as reduction of renal fibrosis in obstructive nephropathy with MSCs and serelaxin, MSC may make great contribution to the improvement of renal pathophysiology. However, the therapeutic effects of MSC are still controversial and several problems remain unsolved. While it is too early to state that MSCs are useful for the treatment of renal diseases in clinic, it is thought that solutions to the existing problems will enable effective modulation of the biological characteristics of MSCs, thereby providing new and effective approaches for the treatment of renal diseases.
topic mesenchymal stem cell
renal fibrosis
regenerative therapy
homing
autocrine
paracrine
url https://www.frontiersin.org/article/10.3389/fphys.2018.01323/full
work_keys_str_mv AT minfan currentperspectivesonroleofmscinrenalpathophysiology
AT jingzhang currentperspectivesonroleofmscinrenalpathophysiology
AT hongxin currentperspectivesonroleofmscinrenalpathophysiology
AT xiaozhouhe currentperspectivesonroleofmscinrenalpathophysiology
AT xuemeizhang currentperspectivesonroleofmscinrenalpathophysiology
_version_ 1716746521004736513